#pancreaticcancermarket
The survival of 80% of the patients are extended by the emergence of new drug therapies and new drug combinations. Obesity and low physical activities are associated to pancreatic cancer. Some nutritional and dietary factors, such as high intake of fats, low intake of vegetables, and consumption of red and progressed meat are the causes behind the rising population suffering from pancreatic cancer disease and dominating the global market by new technological advances in surgical therapies, chemotherapies and radiation therapies.

Pancreatic Cancer Market: Industry Analysis and Forecast (2023-2029)

Pancreatic Cancer Market size was valued at US$ 6.04 Bn. in 2022 and is expected to grow at a CAGR of 7.3% through 2023 to 2029.